cilostazol has been researched along with Heart Septal Defects, Ventricular in 1 studies
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Umazume, T | 1 |
Funabashi, N | 1 |
Inoue, T | 1 |
Nishi, T | 1 |
Shimizu, T | 1 |
Jo, K | 1 |
Ishikawa, T | 1 |
Nakamura, Y | 1 |
Miyazaki, A | 1 |
Kobayashi, Y | 1 |
1 other study available for cilostazol and Heart Septal Defects, Ventricular
Article | Year |
---|---|
Adverse effects of cilostazol on left ventricular function in a patient with a sigmoid shaped interventricular septum.
Topics: Cilostazol; Female; Heart Septal Defects, Ventricular; Humans; Middle Aged; Phosphodiesterase 3 Inhi | 2013 |